Clinical Trials Browser

Expanded_access × carfilzomib × Plasma cell × Clear all

NCT01410500 2017-05-02

Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease

Approved for marketing

Multiple Myeloma

NCT00999414 2015-10-26

2009-32

No longer available

Multiple Myeloma